RLAY
Relay Therapeutics Inc
18.00$
-4.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | -100.0% | – | – | – | -91.2% | -100.0% | – | -57.1% | -88.3% | – | |
| – | -9.4% | +11.6% | +11.6% | -16.7% | -15.9% | – | – | +10.4% | -99.1% | -15.9% | – | – | |
| – | – | – | – | – | – | – | -891.7% | – | – | -61.0% | -86.0% | – | |
| – | -4.9% | +6.3% | +11.6% | -16.7% | -11.2% | +8.4% | -13.4% | +6.8% | -18.8% | +27.3% | +8.4% | – | |
| – | -12.6% | +22.6% | +1.7% | -1.9% | -17.4% | +14.9% | -27.4% | -11.3% | +7.4% | -14.9% | +33.2% | – | |
| – | +6.0% | -2.0% | -51.2% | +125.3% | +4.1% | +350.3% | -82.7% | -22.1% | +436.2% | +21.0% | +12.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -92.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.